diagnosed using tool has mode of inheritance has causal genotype has causal or contributing genetic variation has causal molecular phenotype in guideline Reduced Beta/Alpha Synthesis Ratio Genetic Testing Blood Smear Sickle Beta Thalassemia A compound heterozygous state in which a person has a hemoglobin S allele along with a beta-thalassemia allele. The severity of the condition is determined to a large extent by the quantity of normal hemoglobin produced by the beta-thalassemia gene. Sufficient S Beta-Thalassemia Sickle Cell-Beta Thalassaemia SCDO:0001057 NCIT:C95539 Hb S-Beta Thalassemia Sickle Beta Thalassaemia Sickle Cell Beta Thalassemia Disease Sickle Beta-Thalassaemia Sickle Cell-Beta-Thalassemia Disease Syndrome HbSBetaThal S-Beta Thalassemia Sickle Cell-Beta-Thalassemia HbS-Beta-Thalassemia Syndrome Sickle Cell Disease-S Beta Thalassaemia Hemoglobin S Hemoglobin Profile Assay Sickle Cell Thalassemia Beta Thalassemia Mutation HBB, GLU6VAL Hemoglobin Genotype S/Beta Thalassemia Recommendations for the Management of Sickle Cell Disease in South Africa National Guideline for the Control and Management of Sickle Cell Disease A Parental Guide to Managing Sickle Cell Disease Standards for Clinical Care of Adults with Sickle Cell Disease in the UK Sickle Cell Disease: The Clinical Care Guidelines of the Sickle Cell Unit Consensus Statement on the Care of Patients with Sickle Cell Disease in Canada Sickle Cell Disease in Children, Standards and Guidelines for Clinic Care Evidence-Based Management of Sickle Cell Disease Management of Children with Sickle Cell Disease in Europe: Current Situation and Future Perspectives Reduced or Absent Hemoglobin A Autosomal Recessive Compound Heterozygous